Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - MJ Pharmaceuticals Inc. | Financial_Report.xls |
| EX-31 - EX-31 - MJ Pharmaceuticals Inc. | ex31.htm |
| 10-K - 10-K - MJ Pharmaceuticals Inc. | mjpharmaceuticals10k123114.htm |
Exhibit 32
MJ PHARMACEUTICALS, INC.
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of MJ Pharmaceuticals, Inc. (the Company) on Form 10-K for the period ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Mark Uren, Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
A signed original of this written statement required by Section 906 has been provided to and will be retained by, MJ Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Dated: April 13, 2015
By: /s/ Mark Uren
Mark Uren
Chief Executive Officer, President,
Secretary and Principal Financial Officer